Vanda Pharmaceuticals Inc. (VNDA) Stock Grade

About Vanda Pharmaceuticals Inc.'s fundamentals

Vanda Pharmaceuticals is a biotech company with a market capitalization of $519.8 million that achieved modest revenue growth of 8.7% year-over-year. However, the company is currently unprofitable, operating at a negative net margin of -102.0% and reporting a net loss in its latest annual statement, which means expenses significantly exceed revenues. The company does not pay a dividend, and traditional profitability metrics like P/E ratio and return on equity are not applicable given the loss position.